183 related articles for article (PubMed ID: 28566369)
1. T Cell-Mediated Humoral Immune Responses to Type 3 Capsular Polysaccharide of
Middleton DR; Sun L; Paschall AV; Avci FY
J Immunol; 2017 Jul; 199(2):598-603. PubMed ID: 28566369
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of IgG anti-capsular polysaccharide and antiprotein responses to intact Streptococcus pneumoniae in the presence of cognate CD4+ T cell help.
Khan AQ; Lees A; Snapper CM
J Immunol; 2004 Jan; 172(1):532-9. PubMed ID: 14688364
[TBL] [Abstract][Full Text] [Related]
3. A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies.
Ozdilek A; Huang J; Babb R; Paschall AV; Middleton DR; Duke JA; Pirofski LA; Mousa JJ; Avci FY
mBio; 2021 Jun; 12(3):e0080021. PubMed ID: 34061603
[TBL] [Abstract][Full Text] [Related]
4. A semisynthetic
Schumann B; Hahm HS; Parameswarappa SG; Reppe K; Wahlbrink A; Govindan S; Kaplonek P; Pirofski LA; Witzenrath M; Anish C; Pereira CL; Seeberger PH
Sci Transl Med; 2017 Mar; 9(380):. PubMed ID: 28275152
[TBL] [Abstract][Full Text] [Related]
5. Semisynthetic Glycoconjugate Vaccines To Elicit T Cell-Mediated Immune Responses and Protection against
Feng S; Xiong C; Wang S; Guo Z; Gu G
ACS Infect Dis; 2019 Aug; 5(8):1423-1432. PubMed ID: 31126171
[No Abstract] [Full Text] [Related]
6. Structurally identical capsular polysaccharide expressed by intact group B streptococcus versus Streptococcus pneumoniae elicits distinct murine polysaccharide-specific IgG responses in vivo.
Arjunaraja S; Paoletti LC; Snapper CM
J Immunol; 2012 Jun; 188(11):5238-46. PubMed ID: 22523389
[TBL] [Abstract][Full Text] [Related]
7. Differential idiotype utilization for the in vivo type 14 capsular polysaccharide-specific Ig responses to intact Streptococcus pneumoniae versus a pneumococcal conjugate vaccine.
Colino J; Duke L; Arjunaraja S; Chen Q; Liu L; Lucas AH; Snapper CM
J Immunol; 2012 Jul; 189(2):575-86. PubMed ID: 22706079
[TBL] [Abstract][Full Text] [Related]
8. Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels.
Sen G; Chen Q; Snapper CM
Infect Immun; 2006 Apr; 74(4):2177-86. PubMed ID: 16552048
[TBL] [Abstract][Full Text] [Related]
9. Serotype of Streptococcus pneumoniae capsular polysaccharide can modify the Th1/Th2 cytokine profile and IgG subclass response to pneumococal-CRM(197) conjugate vaccines in a murine model.
Mawas F; Feavers IM; Corbel MJ
Vaccine; 2000 Dec; 19(9-10):1159-66. PubMed ID: 11137252
[TBL] [Abstract][Full Text] [Related]
10. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease.
Emmadi M; Khan N; Lykke L; Reppe K; G Parameswarappa S; Lisboa MP; Wienhold SM; Witzenrath M; Pereira CL; Seeberger PH
J Am Chem Soc; 2017 Oct; 139(41):14783-14791. PubMed ID: 28945368
[TBL] [Abstract][Full Text] [Related]
11. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
12. Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein.
Kamboj KK; Kirchner HL; Kimmel R; Greenspan NS; Schreiber JR
J Infect Dis; 2003 May; 187(10):1629-38. PubMed ID: 12721943
[TBL] [Abstract][Full Text] [Related]
13. A novel ICOS-independent, but CD28- and SAP-dependent, pathway of T cell-dependent, polysaccharide-specific humoral immunity in response to intact Streptococcus pneumoniae versus pneumococcal conjugate vaccine.
Chen Q; Cannons JL; Paton JC; Akiba H; Schwartzberg PL; Snapper CM
J Immunol; 2008 Dec; 181(12):8258-66. PubMed ID: 19050242
[TBL] [Abstract][Full Text] [Related]
14. Noncovalent association of protein and capsular polysaccharide on bacteria-sized latex beads as a model for polysaccharide-specific humoral immunity to intact gram-positive extracellular bacteria.
Colino J; Duke L; Snapper CM
J Immunol; 2013 Sep; 191(6):3254-63. PubMed ID: 23926322
[TBL] [Abstract][Full Text] [Related]
15. Novel strategies for development of next-generation glycoconjugate vaccines.
Avci FY
Curr Top Med Chem; 2013; 13(20):2535-40. PubMed ID: 24066893
[TBL] [Abstract][Full Text] [Related]
16. Engineering a Next-Generation Glycoconjugate-Like Streptococcus pneumoniae Vaccine.
Hill AB; Beitelshees M; Nayerhoda R; Pfeifer BA; Jones CH
ACS Infect Dis; 2018 Nov; 4(11):1553-1563. PubMed ID: 30180541
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory monocytes are critical for induction of a polysaccharide-specific antibody response to an intact bacterium.
Chen Q; Snapper CM
J Immunol; 2013 Feb; 190(3):1048-55. PubMed ID: 23269244
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of a newly developed 13-valent pneumococcal conjugate vaccine in a mouse model.
Park C; Kwon EY; Choi SM; Cho SY; Byun JH; Park JY; Lee DG; Kang JH; Shin J; Kim H
Hum Vaccin Immunother; 2017 May; 13(5):1169-1176. PubMed ID: 27960627
[TBL] [Abstract][Full Text] [Related]
19. [SPECIFIC IMMUNE RESPONSE TO CERTAIN CAPSULE POLYSACCHARIDES OF STREPTOCOCCUS PNEUMONIAE IN HEALTHY BLOOD DONORS AND INDIVIDUALS IMMUNIZED WITH PNEUMOCOCCAL VACCINES].
Vaneeva NP; Yastrebova NE
Zh Mikrobiol Epidemiol Immunobiol; 2015; (5):20-6. PubMed ID: 26829849
[TBL] [Abstract][Full Text] [Related]
20. Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.
Goyette-Desjardins G; Calzas C; Shiao TC; Neubauer A; Kempker J; Roy R; Gottschalk M; Segura M
Infect Immun; 2016 Jul; 84(7):2059-2075. PubMed ID: 27113360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
